SCI & TECH● ELEVATED1h ago · Oct 23, 2026, 5:27 PM
A vaccine designed for each patient achieved a 58% reduction in the risk of relapse in high-risk melanoma
Clarín · global
Cada dosis se construye a partir de la huella única del tumor del paciente.Los datos del ensayo global son considerados un punto de inflexión en la historia oncológica.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH1h agoTikTok's U.S. entity seeking four gigawatts of compute power -- CNBCSeeking Alpha TechSCI & TECH1h agoZelenskyy tells ABC News Starlink network still isn't fully workingABC NewsSCI & TECH2h agoA year ahead of the ‘wrecking ball’: Scientists find new clue to predict when El Niño will strikeEuroNews [en]SCI & TECH2h agoPut the last cell tower in orbitThe Hill